Easy method of assessing volume of prostate adenocarcinoma from estimated tumor area: Using prostate tissue density to bridge gap between percentage involvement and tumor volume

Croatian Medical Journal

Volumn 46, Issue 3, 2005, Pages 423-428

  Torlakovic, Goran ^a,b   Grover, Vaneeta K ^c   Torlakovic, Emina ^a,d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Saskatoon Health Region St Pauls Hospital   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ARTICLE; CALCULATION; CANCER GRADING; CANCER GROWTH; CANCER SIZE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PROSTATE ADENOCARCINOMA; PYCNOMETRY; TUMOR VOLUME;

ADENOCARCINOMA; DENSITOMETRY; HUMANS; MALE; PROSTATIC NEOPLASMS;

EID: 18844437782     PISSN: 03539504     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer. 1990;66:1225-33.
2. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol. 1992;23:258-66.
3. McNeal JE, Bostwick DG, Kindrachuk RA, Redwine EA, Freiha FS, Stamey TA. Patterns of progression in prostate cancer. Lancet. 1986;1:60-3.
4. Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol. 1988;139:1235-41.
5. Byar DP, Mostofi FK. Carcinoma of the prostate: prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Examined by the step-section technique. Cancer. 1972;30:5-13.
6. McNeal JE, Redwine EA, Freiha FS, Stamey TA. Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol. 1988;12:897-906.
7. Ruijter ET, van de Kaa CA, Schalken JA, Debruyne FM, Ruiter DJ. Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications. J Pathol. 1996;180:295-9.
8. Chen ME, Johnston DA, Tang K, Babaian RJ, Troncoso P. Detailed mapping of prostate carcinoma foci: biopsy strategy implications. Cancer. 2000;89:1800-9.
9. Villers A, McNeal JE, Freiha FS, Stamey TA. Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer. 1992;70:2313-8.
10. Bostwick DG, Foster CS. Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer. Semin Urol Oncol. 1999;17:222-72.
11. Bostwick DG. Practical clinical application of predictive factors in prostate cancer. A review with an emphasis on quantitative methods in tissue specimens. Anal Quant Cytol Histol. 1998;20:323-42.
12. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281:1395-400.
13. Epstein JI, Carmichael M, Partin AW, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup. J Urol. 1993;149:1478-81.
14. Epstein JI, Oesterling JE, Walsh PC. Tumor volume versus percentage of specimen involved by tumor correlated with progression in stage A prostatic cancer. J Urol. 1988;139:980-4.
15. DiResta GR, Lee J, Lau N, Ali F, Galicich JH, Arbit E. Measurement of brain tissue density using pycnometry. Acta Neurochir Suppl (Wien). 1990;51:34-6.
16. DiResta GR, Lee JB, Arbit E. Measurement of brain tissue specific gravity using pycnometry. J Neurosci Methods. 1991;39:245-51.
17. Gleason, DF. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology: the prostate. Philadelphia (PA): Lea and Febiger; 1977. p. 171-97.
18. Humphrey PA, Vollmer RT. Intraglandular tumor extent and prognosis in prostatic carcinoma: application of a grid method to prostatectomy specimens. Hum Pathol. 1990;21:799-804.
19. Renshaw AA, Chang H, D'Amico AV. Estimation of tumor volume in radical prostatectomy specimens in routine clinical practice. Am J Clin Pathol. 1997;107: 704-8.
20. McNeal JE. Cancer volume and site of origin of adenocarcinoma in the prostate: relationship to local and distant spread. Hum Pathol. 1992;23:258-66.
21. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA. Capsular penetration in prostate cancer. Significance for natural history and treatment. Am J Surg Pathol. 1990;14:240-7.
22. Carvalhal GF, Humphrey PA, Thorson P, Van Y, Ramos CG, Catalona WJ. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer. 2000;89:1308-14.
23. Partin AW, Epstein JI, Cho KR, Gittelsohn AM, Walsh PC. Morphometric measurement of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol. 1989;141:341-5.
24. Jorgen H, Gundersen G, Boysen M, Reith A. Comparison of semiautomatic digitizer-tablet and simple point counting performance in morphometry. Virchows Arch B Cell Pathol Incl Mol Pathol. 1981;37:317-25.
25. Gundersen HJ, Gotzsche O, Jensen EB, Osterby R. Designing efficient sampling schemes: automatic, semiautomatic, or manual image analysis for stereological studies in biology. In: Reith A, Mayhew TM, editors. Stereology and morphometry in electron microscopy: problems and solutions. New York: Hemisphere Publishing Corporation; 1988. p. 15-21.
26. Schmid HP, McNeal JE. An abbreviated standard procedure for accurate tumor volume estimation in prostate cancer. Am J Surg Pathol. 1992;16:184-91.
27. Miller GJ, Cygan JM. Morphology of prostate cancer: the effects of multifocality on histological grade, tumor volume and capsule penetration. J Urol. 1994;152(5 Pt 2):1709-13.